145 results
Page 2 of 8
8-K
EX-99.1
9whisxshs 5m
31 Mar 21
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
9:01am
8-K
EX-99.1
lgl2e ym0v
26 Mar 20
Atossa Therapeutics Announces Fourth Quarter and Year End 2019 Financial Results and Provides Company Update
8:05am
8-K
EX-99.1
0pz8een
14 May 21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
9:15am
8-K
EX-99.1
oajs pm731qwj
27 Jun 19
Regulation FD Disclosure
12:48pm
424B3
imyj r6hqlg
25 Sep 20
Prospectus supplement
5:00pm
8-K
EX-99.1
lm79bhvumbn3
15 Nov 21
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9:25am
8-K
EX-99.1
ljzy fgvtimp5cizm
13 Aug 20
Atossa Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:30am
424B2
khgw4tdi9dy98w3v0m6n
4 Feb 21
Prospectus for primary offering
4:16pm
424B5
mbn5n
21 Dec 20
Prospectus supplement for primary offering
9:16am
424B3
vhkou4gpws v9b
8 Jan 21
Prospectus supplement
9:15am
424B3
og84rbcrzg qcwwugu8p
11 Dec 20
Prospectus supplement
7:28am
8-K
EX-99.1
f4b ry0we
28 Jun 23
Atossa Therapeutics Announces $10M Stock Repurchase Program
9:01am
DEFA14A
4vx wdqwdzkfw1sz
14 Sep 21
Additional proxy soliciting materials
4:12pm